FindTrial
Sign In

The clinical effect study of transcranial magnetic stimulation on somatoform disorder

The clinical effect study of transcranial magnetic stimulation on somatoform disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015992
Enrollment
Unknown
Registered
2018-05-05
Start date
2016-09-01
Completion date
Unknown
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Somatoform disorder

Interventions

Combined treatment group:Repeat transcranial magnetic stimulation and duloxetine
Drug treatment group:Duloxetine

Sponsors

Nantong Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From January 2016 to December 2016, hospitalized and outpatient patients are eligible for the diagnosis of somatoform disorder in the 10th edition of the statistical classification of international diseases and related health problems (icd-10), aged 18-65 years.

Exclusion criteria

Exclusion criteria: 1. Eliminate severe physical illness; 2. Alcohol and drugs and other psychoactive material dependant; 3. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
HAMD;Somatic symptom scale;TESS;—

Contacts

Public ContactChen Xing

Nantong Fourth People's Hospital

cx109003143@qq.com+86 15152431456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026